Definitive Contract HHSN271201800008C
Award Date 2/8/18
Potential Completion Date 8/14/20
Potential Value $1.5M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Mimetas US Inc., a self-certified small disadvantaged business. The $224,998 Firm Fixed Price contract is for the "Development and Evaluation of the HepaPlate IPS: A High Throughput Organ on a Chip IPS Hepatotoxicity Screening Platform." The contract aims to develop and evaluate a high-throughput organ-on-a-chip...
- This is a $2,000,000 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mimetas US Inc., a self-certified small disadvantaged business based in Montgomery Village, Maryland. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens. This system aims to enable personalized medicine approaches...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) contract to Mimetas US, Inc., a small disadvantaged business, in the amount of $297,962.00. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in...
- This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services (HHS), to Mimetas Operations US, Co., a foreign-owned, self-certified small disadvantaged business. The $150,480.00 contract is for the acquisition of Organoplate Grafts, which are microfluidic 3D cell culture plates used in scientific research projects related to SARS-CoV-2 and COVID-19. This contract was...
- This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract, valued at $1,988,728.00, is for the development of a "vascularized tumor-microenvironment assay" to support the screening of anti-cancer drugs. This contract is designated as a Total Small Business...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Lynntech Inc., a small business. The contract is for the development of non-polydimethylsiloxane (PDMS) biocompatible alternatives for organs-on-chips, a topic under NCATS SBIR 2019 solicitation. The contract has a firm fixed-price of $225,000.00 and a completion date of January 31, 2020. Lynntech Inc. is a small business that...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $142,843.00 firm-fixed-price purchase order to Hesperos, Inc., a leading company in organ-on-a-chip technology, to provide scientific testing services. The contract is for the target validation and therapeutic evaluation of drug compound TRND00601748-01 in NGLY1 deficient cell-based models, including motoneurons and neuromuscular junction models. This...
- This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit small business, for the delivery of 96-well plate assemblies with a biodegradable membrane. The $894,612.11 firm-fixed-price purchase order contract has a completion date of September 15, 2020. The original solicitation was a combined synopsis/solicitation for commercial items, with the...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...